Management of Failing Kidney and Pancreas Transplantations

Michelle Lubetzky,Krutika Chauhan,Louai Alrata,Casey Dubrawka,Farah Abuazzam,Samer Abdulkhalek,Tarek Abdulhadi,Dema Yaseen Alsabbagh,Neeraj Singh,Krista L Lentine,Bekir Tanriover,Tarek Alhamad
DOI: https://doi.org/10.1053/j.akdh.2024.07.001
Abstract:Survival rates for allografts have improved over the last 2 decades, yet failing allografts remains a challenge in the field of transplant. The risks of mortality and morbidity associated with failed allografts are compounded by infectious complications and metabolic abnormalities, emphasizing the need for a standardized approach to management. Management of failing allografts lacks consensus, highlighting the need for unified protocols to guide treatment protocols and minimize risks with postdialysis initiation. The decision to wean off immunosuppression depends on various factors, including living donor availability and infectious risks, necessitating improved coordination of care and a standard guideline. Treatment of failed pancreas focuses on glycemic control, with insulin as the mainstay, while considering surgical interventions such as graft pancreatectomy in advanced symptomatic cases. Navigating the complexities of failed allograft management demands a multidisciplinary approach and standardized stepwise protocol. Addressing the gaps in management plans for failing allografts and employing a systematic approach to transplant decisions will enhance patient outcomes and facilitate informed decision-making.
What problem does this paper attempt to address?